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Food-derived peptides, such asβ-casomorphin BCM7, havepotential to cross the gastrointestinal tract and blood–brain barrier and are associatedwith neurological
disorders and neurodevelopmental disorders. We previously established a novel mechanism through which BCM7 affects the antioxidant levels in neuronal cells
leading to inflammatory consequences. In the current study,weelucidated the effects of casein-derivedpeptides onneuronal development by using theneurogenesis of
neural stem cells (NSCs) as an experimental model. First, the transient changes in intracellular thiol metabolites during NSC differentiation (neurogenesis) were
investigated. Next, the neurogenic effects of food-derived opioid peptidesweremeasured, alongwith changes in intracellular thiolmetabolites, redox status and global
DNA methylation levels. We observed that the neurogenesis of NSCs was promoted by human BCM7 to a greater extent, followed by A2-derived BCM9 in contrast to
bovine BCM7, which induced increased astrocyte formation. The effect was most apparent when human BCM7 was administered for 1 day starting on 3 days
postplating, consistentwith immunocytochemistry. Furthermore, neurogenic changes regulated bybovine BCM7andmorphinewere associatedwith an increase in the
glutathione/glutathione disulfide ratio and a decrease in the S-adenosylmethionine/S-adenosylhomocysteine ratio, indicative of changes in the redox and the
methylation states. Finally, bovine BCM7 and morphine decreased DNA methylation in differentiating NSCs. In conclusion, these results suggest that food-derived
opioid peptides and morphine regulated neurogenesis and differentiation of NSCs through changes in the redox state and epigenetic regulation.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords: Neurogenesis; Neuronal stem cells; Epigenetic regulation; Redox state; Casein-derived opioid peptides1. Introduction
Proteins present in food undergoproteolysis to yield short peptides
of varying length, as well as amino acids. Some food-derived peptides
are able to cross the gastrointestinal epitheliumand enter the systemic
circulation [1,2], and some may also cross the blood–brain barrier
[3,4]. Furthermore, some reports have described associations between
food-derived peptides and neurological disorders, like autism [4–7],
schizophrenia [8–12] and delayed psychomotor development in
infants [13].Abbreviations: BCM,β-casomorphin; bBCM7, bovine form of BCM7; bBCM9,
bovine form of BCM9; hBCM7, human form of BCM7; bFGF, basic ﬁbroblast
growth factor; BrdU, bromodeoxyuridine; CYS, cysteine; CYS2, cystine; dpp,
days postplating; EGF, epidermal growth factor; GSH, glutathione; GSSG,
glutathione disulﬁde; HCY, homocysteine; HCY2, homocystine; HPLC, high-
performance liquid chromatography; MET, methionine; NSC, neural stem cell;
SAH, S-adenosylhomocysteine; SAM, S-adenosylmethionine.
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particular interest in recent years owing to its potential neurological
affects, as well as other immune- and inﬂammation-related
properties [14–17]. BCM7 is mainly produced by the proteolysis of
A1β-casein [18], amajor component of cows’milk that displays opioid
activity [19]. Although associations between BCM7 and neurological
disorders, especially neurological development in infants [13], have
been identiﬁed, the underlying mechanism has not yet been
evaluated. Therefore, we sought to investigate the potential neuro-
logical effects of BCM7 and other related peptides on neurological
development, using the neurogenesis of neural stem cells (NSCs) as a
research model.
We have previously reported that proline-rich opioid peptides
derived from milk or wheat reduced cysteine uptake in cultured
human neuronal and gastrointestinal epithelial cells by activating opioid
receptors [20]. Decreases in cysteine uptake were associated with
alterations in intracellular glutathione (GSH) and S-adenosylmethionine
(SAM). Moreover, bovine and human casein-derived opioid peptides
increased genome-wide DNA methylation in transcription start site
regions, which affected the expression of genes involved in redox and
methylation homeostasis. These results suggest that milk- and wheat-
derived peptides exert antioxidant and epigenetic changes that may
be important during the postnatal transition from placental tothe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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breastfed and formula-fed infants.
The redox state and epigenetic modiﬁcations are known to
inﬂuence neural development [21]. For example, it was reported
that inhibition of the eicosanoid signaling pathway promoted
pluripotency and maintained levels of unsaturated fatty acids, while
downstream oxidized metabolites (e.g., neuroprotectin D1) and
substrates of prooxidative reactions (e.g., acyl-carnitines) promoted
neuronal and cardiac differentiation of embryonic stem cells [22].
Regarding neural development, it has been reported that hypoxia
promotes neurogenesis in embryos, newborns and adults in vivo and
that oxygen and reactive oxygen species also play a role in neuronal
differentiation in vitro [23]. Meanwhile, exposure to morphine
inhibited the proliferation of neural progenitor cells and increased
active caspase-3 expression in a dose-dependent manner in vitro [24].
Morphine also enhanced neuronal and glial differentiation. These
effects were reversed by the opioid antagonist naloxone. These results
highlight important roles of opioid receptors in the regulation of
neural progenitor cell survival. In relation to these ﬁndings, it has been
reported that maternal inﬂammation is associated with brain
overgrowth and autism-associated behaviors, as a consequence of
altered redox signaling in neural stem and progenitor cells [25].
Considering this background, and to elucidate the effects of food-
derived peptides on neuronal development, we performed three
experiments with the following objectives: Experiment 1 — to
investigate the transient changes in intracellular thiolmetabolites during
NSCdifferentiation; Experiment 2— to investigate the neurogenic effects
of opioid peptides in differentiating NSCs; and Experiment 3 — to
measure the changes in intracellular thiol levels in differentiated NSCs
exposed to opioid peptides at 3 days postplating (dpp).
2. Methods
2.1. NSC cultures
Previously isolatedandfrozenneuronal stemcell cultureswereproperly
thawed,maintained and cultured for the current experiments as previously
described [26]. Cell suspensions were grown in a deﬁned medium (DF12)
composed of DMEM/F12 (1:1), 2 mM L-glutamine, 1 mM sodium pyru-
vate, antibiotics/antimycotics (Invitrogen, Grand Island, NY), 0.6% glucose,
25 μg/ml insulin, 20 nM progesterone, 60 μM putrescine, 30 nM sodium
selenite (all from Sigma, St. Louis, MO), 100 μg/ml human transferrin
(Roche, Indianapolis, IN), 20 ng/ml human recombinant endothelial
growth factor [epidermal growth factor (EGF); Roche or Invitrogen,
Chicago, IL] and basic ﬁbroblast growth factor (bFGF; Upstate
Biotechnology, Lake Placid, NY). The cells grew as free-ﬂoating
aggregates (neurospheres) and were passaged by mechanical dissoci-
ation every 3–4 days. After a minimum of four passages, the cells were
plated at a density of 18,000 cells/cm2 on eight-well glass slide
chambers (Nalge Nunc International, Naperville, IL) coated with
15 μg/ml poly-L-lysine (Sigma). Cultures were maintained in DF12
and EGF or EGF plus bFGF for 3 days and then switched to DF12 without
growth factors for longer culture periods. Immunocytochemical studieswere
performed at different time points between 3 and 10 dpp. To analyze the
effectsof opioidpeptides, thecellswere treatedwith10 μMconcentrationsof
morphine, human hBCM7, bovine bBCM7 and bBCM9 (American Peptide,
Sunnyvale, CA). Peptideswere reconstituted in sterilewater and incubated at
37°C for 1 day or 3 days. Parallelwellsweremaintained inDF12without the
test peptides (untreated group). Immunocytochemical analyses were
performed at 1, 3 or 10 days after treatment.
2.2. Isolation of intracellular thiol metabolites
Intracellular thiol metabolites were measured as previously
described [27,28]. Brieﬂy, neuronal stem cell cultures were grown toconﬂuence in stem-cell-speciﬁc growthmedia as described above and
were then incubated with the indicated drugs for speciﬁc times.
Themediumwas aspirated and the cells werewashed twicewith 1 ml
of ice-cold HBSS. Then, the HBSS was aspirated and 0.6 ml of ice-
cold dH2O was added to the cells and the cells were scraped from the
ﬂask/dish. The cell suspensionwas sonicated for 15 s on ice and 100 μl
of the sonicate was used to determine protein content. The remaining
lysate was added to a microcentrifuge tube with an equal volume of
0.4 N perchloric acid and incubated on ice for 5 min. Samples were
centrifuged at 10,000g and the supernatant was transferred to new
microcentrifuge tubes. Then, 100 μl of the sample was added to a
conical microautosampler vial and kept at 4°C in the autosampler
cooling tray. Finally, 10 μl of this sample was injected into a high-
performance liquid chromatography (HPLC) system.
2.3. HPLC measurement of intracellular thiols
Concentrations of the following metabolites were measured:
cysteine (CYS), cystine (CYS2), glutathione (GSH), glutathione disulﬁde
(GSSG), homocysteine (HCY), homocystine (HCY2),methionine (MET),
S-adenosylhomocysteine (SAH) and S-adenosylmethionine (SAM). As
previously described [25,26], the redox and methylation pathway
metabolites were separated using an Agilent Eclipse XDB-C8 analytical
column (3×150 mm; 3.5 μm) and an Agilent Eclipse XDB-C8
(4.6×12.5 mm; 5 μm) guard column. Two mobile phases were used.
Mobile phase A comprised 0% acetonitrile, 25 mM sodium phosphate
and 1.4 mM1-octanesulfonic acid, adjusted to pH 2.65withphosphoric
acid. Mobile phase B was 50% acetonitrile. The ﬂow rate was initially
set at 0.6 ml/min and a step gradient was used, as follows: 0–9 min 0%
B, 9–19 min 50% B and 19–30 min 50% B. The column was then
equilibrated with 5% B for 12 min before the next run. The column
temperaturewasmaintained at 27°C. The electrochemical detectorwas
an ESA CoulArray with BDD Analytical Cell Model 5040 and the
operating potential was set at 1500 mV. Sample concentrations were
determined from the peak area for each metabolite using standard
calibration curves and ESA software and then normalized for protein
concentration. Some samples were diluted in the mobile phase, as
needed, or up to 50 μl of sample was injected to ensure the thiol
concentration was within the range of the standard curve.
2.4. Assessment of cell proliferation and apoptosis
To identify proliferating cells, 100 μM bromodeoxyuridine (BrdU), an
analog of thymidine, was added 24 h before cell ﬁxation. After perme-
abilization with ethanol acetic solution (19:1), cells were treated with 2 N
HCl for 30 min at 4°C to denature DNA. A primary monoclonal antibody
against BrdU(1:20;Dakopatts)was added for1 hat roomtemperatureand
detected using AlexaFluor 488-labeled goat antimouse IgG (H+L). This
methodallowedus to identify cells thathadduplicated theirDNA in the last
24 h. Apoptotic cells were visualized with Hoechst 33342 (Life Technolo-
gies, MD) as fragmented pycnotic blue-stained nuclei and counted under
the ﬂuorescence microscope as previously described [26].
2.5. Indirect immunocytochemistry
Cells were ﬁxed with 4% paraformaldehyde for 20 min, perme-
abilized with an ethanol–acetic acid solution (19:1) at 20°C for
20 min, blocked with 10% fetal bovine serum and incubated with
primary antibodies overnight at 4°C. Sister cultures served as negative
controls and were similarly processed, except for incubation without
the primary antibody in each case. Immunoﬂuorescence was used for
detection of all antigens.Monoclonal antinestin (clone Rat 401; 1:200)
was obtained from the Developmental Studies Hybridoma Bank
(University of Iowa, Iowa City, IA). Polyclonal antiglial ﬁbrillary acid
protein (1:500) was purchased from Dakopatts (Glostrup, Denmark).
Fig. 1. Concentrations of thiols during the differentiation of NSCs at d 0, 1, 3, 7 and 10 days. (A) Concentrations of 10 thiols measured using HPLC. (B) GSH/GSSG ratios as a marker of the
redox status of cells at 0, 1, 3, 7 and 10 days of differentiation. Values are presented as the percent andwere normalized to the ratios in control cells. (C) SAM/SAH ratios as amarker of the
methylation status of cells at 0, 1, 3, 7 and 10 days of differentiation. Values are presented as the percent and were normalized to the ratios in control cells. (D) Total DNAmethylation
status. Values are presented as the percent of CpG methylation and were normalized to the values in control cells. Data are presented as the mean±SEM of normalized data versus
control cells fromone representative experiment of a total of four experiments done in quadruplicate. *Pb.05, **Pb.01 and ***Pb.001 versusﬂoatingNSCs (i.e., day 0) (ANOVA followed by
the Bonferroni post hoc test). CYS: cysteine, CYS2: cystine, GSH: glutathione, GSSG: glutathione disulﬁde, HCY: homocysteine, HCY2: homocystine, MET: methionine, SAH: S-
adenosylhomocysteine, SAM: S-adenosylmethionine.
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tubulin isotype III (1: 2000) were purchased from Covance
(Richmond, CA). Polyclonal anti-O1 (1:5) was obtained from a
hybridoma purchased fromAmerican Type Culture Collection (Manassas,
VA). Monoclonal anti-BrdU (1:50) was obtained from Dako (High
Wycombe, UK), and monoclonal antineuronal nuclei (NeuN) was
obtained from Chemicon (Temecula, CA). For single labeling of neural
antigens, goat antimouse IgG (H+L) or goat antirabbit IgG (H+L) labeled
with AlexaFluor 568 or AlexaFluor 488 was purchased from Molecular
Probes (Eugene, OR).
2.6. Isolation of genomic DNA
Genomic DNA was isolated from cultured cells to measure global
DNA methylation as previously described [27,28]. DNA was isolated
from harvested cells using FitAmp Blood and Cultured Cell DNA
Extraction Kits (Epigentek, Farmingdale, NY). The isolated DNA
was cleaned for any contaminating RNA by treatment with RNase
enzyme and quantiﬁed using ND-1000 NanoDrop spectrophotometer
(Thermo Scientiﬁc).2.7. Measurement of global DNA methylation
Global DNAmethylation analysis was performed usingMethylFlash
Methylated DNA Quantiﬁcation Kits according to the manufacturer’s
instructions (Epigentek). Brieﬂy, 100 ng of clean genomic DNA was
used and DNA methylation was quantiﬁed using 5-methylcytosine
monoclonal antibodies in an enzyme-linked immunosorbent assay–like
reaction, as previously described [27,28]. The levels of methylated DNA
were calculated based on the optical density of each well on a
microplate reader at 450 nm. Results were normalized against a
standard curve prepared using the kit’s methylated standards ranging
from 0% to 100%.
2.8. Data analysis
Results are expressed as the mean±standard error of the mean
(SEM) of direct counts of positive cells for each antibody from
independent experiments done in triplicate or quadruplicate. Where
indicated, the data were normalized relative to the relevant control
group. In each culture, 25 predetermined visual ﬁelds were counted
Fig. 2. Neurogenic effects of peptides. NSCs from the hippocampus were treated with 10 μM of the indicated peptides for 1 or 3 days starting on 0, 3 or 7 dpp. Neurons (A), apoptotic
nuclei (B) and the total number of cells (C) were counted. Data are presented as themean±SEM of normalized data versus control cells from one representative experiment of a total of
four experiments done in quadruplicate. **Pb.01 and ***Pb.001 versus control cells (ANOVA followed by the Bonferroni post hoc test). bBCM7: bovine form of β-casomorphin-7, bBCM9:
bovine form of β-casomorphin-9, hBCM7: human form of β-casomorphin-7.
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corrected for the total number of cells in the same area, with Hoechst
nuclear staining. Statistical analyses were performed using analysis of
variance with the Bonferroni post hoc test or Student’s t test as
appropriate. Differences were considered signiﬁcant at Pb.05. All
statistical analyseswere conducted using Prism6.0 software (GraphPad
Software, San Diego, CA).3. Results
3.1. Transient changes in intracellular thiol metabolites during
NSC differentiation
Previous reports have indicated changes in the intracellular
concentrations of thiol metabolites during the differentiation of
embryonic stem cells [20]; however, little is known about the changes
in thiols during the differentiation of NSCs. Therefore, we ﬁrst
investigated the changes in thiol metabolites during the differentia-
tion of NSCs. Fig. 1 shows the concentrations of 10 thiolsmeasured at 0
(ﬂoating NSCs), 1, 3, 7 and 10 dpp. Of the 10 thiols measured, the
concentrations of CYS and GSH were markedly greater than those of
the other thiols in ﬂoating NSCs. The concentrations of both thiols
decreased signiﬁcantly with ongoing differentiation (Pb.05 for both
thiols at 1, 3, 7 and 10 dpp vs. 0 dpp). Signiﬁcant reductions in the
GSH/GSSG ratio (Fig. 1B) and SAM/SAH ratio (Fig. 1C) were also
observed in differentiating NSCs. The GSH/GSSG ratio tended to showprogressive reductions with time since plating. By contrast, after the
initial reduction in the SAM/SAH ratio at day 1, it remained relatively
constant thereafter.
3.2. Epigenetic changes during NSC differentiation
To examine whether the changes in thiol metabolites were
associated with altered DNA methylation, we assessed the methyla-
tion state of CpG sites. In this experiment, we found that global DNA
methylation levels increased slightly at 1 and 3 dpp compared with
0 dpp (Fig. 1D), but then it decreased at 7 and 10 dpp to values below
the value at 0 dpp. It is noteworthy to mention that the assay employed
in this study did not differentiate between the 5-methylcytosine and
5-hydroxymethylcytosine marks; however, we did see changes in
the global DNA methylation levels.
3.3. Effects of opioid peptides on NSC differentiation
We next examined the effects of opioid peptides on NSC
differentiation. Fig. 2A shows that administration of opioid peptides
for 1 or 3 days startingon3 dpphad a neurogenic effect (i.e., enhanced
proliferation) compared with control cells. This effect was most
apparent in cells treated with hBCM7 for 1 day starting on 3 dpp.
Although extending administration to 3 days still had a neurogenic
effect, this effect was muted compared with administration for 1 day.
Starting administration of the peptides on 0 or 7 dpp did not appear to
Fig. 3. Immunocytochemistry of differentiating NSCs. Scale bar, 25 μm. bBCM7: bovine form of β-casomorphin-7, bBCM9: bovine form of β-casomorphin-9, hBCM7: human form of β-
casomorphin-7.
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of the duration of administration. The effects of these peptides on
apoptosis (Fig. 2B) and the total number of cells (Fig. 2C) were highly
variable with no consistent pattern, except for increases in apoptosis
and decreases in the total cell counts during the later stages of
differentiation; these effects were particularly evident in NSCs treated
with morphine. These neurogenic effects of the opioid peptides were
conﬁrmed by immunocytochemistry of NSCs treated with the four
peptides for 1 day after 3 dpp (Fig. 3).
3.4. Effects of opioid peptides on intracellular thiol levels of
differentiating NSCs at 3 dpp
In our prior report, we showed that exposure to morphine, bBCM7
and hBCM7 for 4 and 24 h affected thiol metabolites including the
GSH/GSSG and SAM/SAH ratios in SH-SY5Y neuroblastoma cells [20].
In the present study, we observedmarked changes in thiol metabolite
concentrations during differentiation (Fig. 1). Therefore, we investi-
gated the combined effects of food-derived opioid peptides on thiol
concentrations during differentiation. We treated the NSCs as
described above and measured the thiol metabolites using HPLC
coupled to an electrochemical gradient detector. The effects of opioidpeptides (morphine, bBCM7, hBCM7andbBCM9) on intracellular thiol
levels in differentiating NSCs are presented in Fig. 4. The four peptides
had varying effects on the thiols measured in this study. In particular,
morphine, bBCM7 and bBCM9 signiﬁcantly reduced CYS concentra-
tions, while hBCM7 elicited a small, nonsigniﬁcant decrease in CYS
concentrations, compared with the control conditions. hBCM7 and
bBCM9 signiﬁcantly reduced the GSH concentration, whereas mor-
phine and bBCM7 signiﬁcantly increased the GSH concentration
(Fig. 4A). Administration of bBCM7 or morphine signiﬁcantly
increased the GSH/GSSG ratio (Fig. 4B) and signiﬁcantly decreased
the SAM/SAH ratio (Fig. 4C). Neither of these ratios was affected by
hBCM7 or bBCM9.
3.5. Effects of opioid peptides on CpG methylation
In our prior reports, we found that exposure to morphine and food-
derived opioid peptides inﬂuenced DNA methylation in SH-SY5Y
neuroblastoma cells [20,28]. Here, we observed that that the four opioid
peptides under investigation tended todecrease global 5-methylcytosine
levels as compared to control cells during differentiation phenomenon,
although the changes were not statistically signiﬁcant (Fig. 4D). It is
intriguing to note that hBCM7had a greater effect on CpGmethylation at
Fig. 4. Thiol concentrations at 3 dpp and the effects of peptide exposure for 1 day on the differentiation of NSCs. (A) Concentrations of 10 thiols after 1 day of treatment with the
indicated peptides starting on 3 dpp. (B) GSH/GSSG ratios as amarker of the redox status of cells at 0, 1, 3, 7 and 10 days of differentiation. Values are presented as the percent andwere
normalized to the ratios in control cells. (C) SAM/SAH ratios as a marker of the methylation status of cells at 0, 1, 3, 7 and 10 days of differentiation. Values are presented as the percent
andwere normalized to the ratios in control cells. (D) Total DNAmethylation status. Values are presented as the percent of CpGmethylation andwere normalized to the values in control
cells. Data are presented as the mean±SEM of normalized data versus control cells from one representative experiment of a total of four experiments done in quadruplicate. *Pb.05,
**Pb.01 and ***Pb.001versusﬂoatingNSCs (i.e., day 0) (ANOVA followedby the Bonferronipost hoc test). bBCM7:bovine formofβ-casomorphin-7, bBCM9:bovine formofβ-casomorphin-9,
CYS: cysteine, CYS2: cystine, GSH: glutathione, GSSG: glutathione disulﬁde, hBCM7: human form of β-casomorphin-7, HCY: homocysteine, HCY2: homocystine,MET:methionine,
SAH: S-adenosylhomocysteine, SAM: S-adenosylmethionine.
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related to the diverging effects of these opioids on the redox state,
especially the GSH/GSSG and SAM/SAH ratios as discussed above in this
study and in our prior study [20].
4. Discussion
Plasma and brain GSH levels are decreased in a variety of
neurodevelopmental, neurological/neurodegenerative and psycho-
logical disorders [29,30], indicative of a pivotal role of oxidative stress
in these disorders [31]. Concurrent decreases in cerebrospinal ﬂuid
SAM concentrations and the SAM/SAH ratio have been reported in
patients with Alzheimer’s disease [32], and the cognitive function of
patients with Parkinson’s disease was positively associated with the
SAM/SAH ratio [33]. In a postmortem brain study [34], we demon-
strated a decrease in methionine synthase expression across the
lifespan and proposed that progressive changes in redox state
translate into epigenetic and metabolic adaptations.
There were three key ﬁndings of this study. First, the levels of
cysteine and GSH as well as the GSH/GSSG ratio in NSCs progressively
decreased in association with neuronal differentiation. Second,
administration of hBCM7 promoted NSC neurogenesis to a greaterextent than did administration of the other opioid peptides tested,
including bBCM7, and this effect was most apparent when hBCM7 was
administered for 1 day starting on 3 dpp. Third, administration of
the opioid peptide bBCM7 and morphine signiﬁcantly increased the
GSH/GSSG ratio and decreased the SAM/SAH ratio compared with the
ratios in control cells. Redox regulation as well as the intracellular levels
of antioxidants such as GSH and the methyl donor SAM are important
regulatory factors in NSC differentiation. Essentially, the NSC differen-
tiation can also be viewed as an adaptive response to oxidative stress,
under the inﬂuence of permissive epigenetic changes. SAM is the main
methyl donor in transmethylation reactions, includingDNAmethylation
and contributes to epigenetic regulation of gene transcription. The folate
and vitamin B12-dependent enzymemethionine synthase controls SAM
levels and exerts global control over the methylation state, including
DNAmethylation. Interestingly, methionine synthase is highly sensitive
to the redox state and provides amechanism bywhich a decrease in the
GSH/GSSG ratio can promote epigenetic changes, which could contrib-
ute to the differentiation process. Similar to our previous observations,
in the present study, we observed marked changes not only in the
GSH/GSSG ratio but also in the SAM/SAH ratio in NSCs.
It can also be inferred from the current results that exposure
to opioid peptides can alter neurogenesis, as well as GSH/GSSG and
Fig. 5. Redox-dependent epigenetic regulation of NSCs by μ opioid receptors. GSH:
glutathione, GSSG: glutathione disulﬁde, SAH: S-adenosylhomocysteine, SAM: S-
adenosylmethionine.
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negligible effects in the initial (i.e., exposure from 0 dpp) and late (i.e.,
exposure from7 dpp) stages of neurogenesis, and longer exposure did
not appear to enhance the neurogenic effects (Figs. 3 and 4). In the
present study, we found that exposure to morphine and food-derived
peptides had signiﬁcant effects on the differentiation pattern and
neurogenesis only during a certain time interval. This could be
attributed to the critical timeframe of adaptive epigenetic changes
under the inﬂuence of redox changesmediated by the opioid peptides.
Hence, based on these results and our recently published data, we
suggest that opioid peptides alter cellular cysteine levels resulting in
altered redox state and DNA methylation, subsequently leading to
altered gene expression as well as inducing skewed neurogenesis and
differentiation trajectory (Fig. 5). However, this is deﬁnitely a
possibility that should be examined in vivo for conﬁrmation.
It is also intriguing to note the divergent effects of bBCM7 and
hBCM7 on redox status and neurogenesis. Although the mechanismsunderlying the differential effects of these two peptides are unclear, it
is possible that bBCM7has a stronger agonistic activity toward μ opiate
receptors expressed onNSCs, causing greater changes in the redox and
methylation states (Fig. 5). Similar distinctive effects of hBCM7 and
bBCM7 were observed in our prior study in SH-SY5Y neuroblastoma
cells [20]. These differential effects of hBCM7 and bBCM7 might also
contribute to the health beneﬁts of breastfeeding relative to formula
feeding in early infancy; however, we did not conduct any direct
investigation for the same and it is an extrapolation. However,wehave
previously reported an association between the length of breastfeed-
ing and incidence of autism in kids in Oman [35]. It is important
to consider that BCM7 is primarily derived from the proteolysis of A1
β-casein, which is the predominant β-casein type in cows’ milk [18].
These study outcomes warrant further investigation; in particular,
it will be necessary to examine the downstream cellular mechanisms
involved in the differential effects of hBCM7 and bBCM7. Additionally,
because the results obtained here were derived from NSCs in vitro, it
will be necessary to verify these ﬁndings in vivo. Finally, considering
the impact on methylation status, it would be informative to
determine whether the methylation state of NSCs has global
epigenetic effects or whether certain groups of genes (e.g., those
involved in differentiation or redox reactions) are targeted in this
process at their promoter region.
5. Conclusions
In conclusion, the results of this study reveal that the neurogenesis
of NSCs is promoted by hBCM7 to a greater extent than by other opioid
peptides. In fact, bBCM7 promotes higher astrocyte differentiation.
The effect of hBCM7 was prominent when administered for 1 day
starting on 3 dpp. The neurogenic changes regulated by bBCM7 and
morphine were associated with an increase in the GSH/GSSG ratio, a
decrease in the SAM/SAH ratio and a decrease in CpG methylation.
These results suggest that opioid peptides derived from β-casein can
inﬂuence neurogenesis via redox-based epigenetic effects. Especially
peptides like bBCM7 can skew the neurogenic potential of NSC.Acknowledgments
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